Videos de Experimentos Relacionados
Progreso en el cáncer de recto.
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Lancet (London, England)
|December 14, 1996
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Quality of life with first-line pembrolizumab for PD-L1-positive advanced gastric/gastroesophageal junction adenocarcinoma: results from the randomised phase III KEYNOTE-062 study.
ESMO open·2021
Same author
Molecular determinants of clinical outcomes with pembrolizumab versus paclitaxel in a randomized, open-label, phase III trial in patients with gastroesophageal adenocarcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author
Poster abstracts of the 18th Pan Arab Cancer Congress. TUNISIA. April 19-21, 2018.
La Tunisie medicale·2018
Same author
Plasma inflammatory cytokines and survival of pancreatic cancer patients.
Clinical and translational gastroenterology·2018
Same author
Meta-analysis of individual patient safety data from six randomized, placebo-controlled trials with the antiangiogenic VEGFR2-binding monoclonal antibody ramucirumab.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author
How health-related quality of life assessment should be used in advanced colorectal cancer clinical trials.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same journal
Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.
Lancet (London, England)·2026
Same journal
The US Ebola response and the future of global health leadership.
Lancet (London, England)·2026
Same journal
The 2026 Wakley-Wu Lien Teh Prize Essay: why medicine, and why stay?
Lancet (London, England)·2026
Same journal
Indonesia's health reform: from pandemic mandate to the six pillars of transformation.
Lancet (London, England)·2026